Streetbeat News

Equity Actions

EKSO

Ekso Bionics has entered into a securities purchase agreement with institutional investors to sell 2.9 million shares at a price of $1.55 per share. The transaction is expected to generate gross proceeds of approximately $4.6 million for the company.

Portfolio Pulse from Benzinga Newsdesk

January 11, 2024 | 1:05 pm

RNAZ

Transcode Therapeutics has announced a 1-for-40 reverse stock split, which will be effective at 12:01 a.m. Eastern Standard Time on January 16.

Portfolio Pulse from Benzinga Newsdesk

January 11, 2024 | 1:03 pm

EKSO

Ekso Bionics has announced a registered direct offering of 2,967,742 shares at a price of $1.55 per share, aiming to raise approximately $4.6 million. This capital raise could dilute current shareholders but also provides the company with additional funds for operations, development, and potential expansion.

Portfolio Pulse from Benzinga Newsdesk

January 11, 2024 | 1:01 pm

WRK

WestRock (NYSE:WRK) was analyzed by 4 analysts, maintaining an 'Indifferent' consensus with no change in sentiment over the past 3 months. The average 12-month price target is $43.25, up 5.49% from the previous $41.00. Analysts from Wells Fargo, Truist Securities, and RBC Capital have adjusted their price targets, reflecting a response to market dynamics and company performance. WestRock, a major packaging manufacturer, shows a negative revenue trend, below-average net margin, but strong ROE and ROA, and a conservative debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

January 11, 2024 | 1:00 pm

URI

United Rentals (NYSE:URI) has seen an 11.04% increase in short interest since its last report, with 3.88 million shares sold short, representing 6.54% of its float. It would take about 4.58 days to cover all short positions. While this rise in short interest could indicate bearish sentiment, it doesn't necessarily predict a near-term price drop. United Rentals has a higher short interest compared to its peer group average of 4.94%.

Portfolio Pulse from Benzinga Insights

January 11, 2024 | 1:00 pm

DLTR

Dollar Tree (NYSE:DLTR) has seen a 12.79% increase in short interest since its last report, with 8.94 million shares sold short, representing 4.94% of its float. It would take about 3.91 days to cover these short positions based on average trading volume. While an increase in short interest can indicate bearish sentiment, it does not necessarily predict a near-term price decline. Dollar Tree has a higher short interest than its peer group average of 4.05%.

Portfolio Pulse from Benzinga Insights

January 11, 2024 | 1:00 pm

LUNR

Intuitive Machines has entered into a warrant exercise transaction, resulting in gross proceeds of $11.8 million. This financial move could potentially bolster the company's capital and support its growth or operational strategies.

Portfolio Pulse from Benzinga Newsdesk

January 11, 2024 | 12:34 pm

PRAX

Praxis Precision Medicines has announced the pricing of its underwritten public offering of 3.17 million shares at $35.50 per share and pre-funded warrants to purchase up to 1.06 million shares at $35.4999 per warrant. The gross proceeds from the offering are expected to be approximately $150 million.

Portfolio Pulse from Benzinga Newsdesk

January 11, 2024 | 12:34 pm

NLOP

Net Lease Office Properties (NLOP) sold four U.S. office properties in December 2023 for gross proceeds of about $43.1 million.

Portfolio Pulse from Benzinga Newsdesk

January 11, 2024 | 12:31 pm

CHWY

Analyst ratings for Chewy (NYSE:CHWY) show a mix of opinions with 17 analysts offering ratings in the last three months. The average 12-month price target is $26.71, down 14.47% from the previous $31.23. Recent actions include both raised and lowered ratings and price targets by analysts from firms such as Barclays, Jefferies, Needham, RBC Capital, Goldman Sachs, Morgan Stanley, JMP Securities, Raymond James, Piper Sandler, Wedbush, UBS, and B of A Securities. Chewy's financials indicate a strong market position with a market cap that asserts dominance, a revenue growth rate of 8.15%, a net margin of -1.31%, an ROE of -9.45%, an ROA of -1.23%, and a debt-to-equity ratio of 1.34.

Portfolio Pulse from Benzinga Insights

January 11, 2024 | 12:00 pm